Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Nextech3D.ai Announces First New Customer Win For its AI Powered Photography Studio (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Rize Oncology Inc C.RIZE

Alternate Symbol(s):  RZONF

Healthcare Biotechnology
Rize Oncology Inc., formerly GeneTether Therapeutics Inc., is a pharmaceutical company engaged in developing oncology therapies. The Company is focused on advancing treatments for soft tissue sarcoma. It is developing STS-201 for the treatment of soft tissue sarcoma. STS-201 is a small-molecule drug candidate that has exhibited significant utility in soft tissue sarcoma, as well as other types of cancers and certain proliferative diseases.


CSE:RIZE - Post by User

Rize Oncology Inc
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(18)
•••
Post by CashFlowRealityon Mar 12, 2024 3:19pm
78 Views
Post# 35929024

Yeap ... people are buying at 0.05

Yeap ... people are buying at 0.05This might pop positive soon... just speculating here (but I do see valuations in the 0.05 range).
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities